Go On, Admit Defeat

genomeweb
360dx

Go On, Admit Defeat

Jun 27, 2008

Gene Essence, says Daniel MacArthur, is a good example of those personal genomics companies that will hopefully fall to the cease-and-desist guns.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Active Celiac Disease Processes Informed by Intestinal Expression Comparison
Amercian Cancer Society Philanthropic Fund BrightEdge Invests in Castle Bio
PetaGene Inks Reseller Agreement With NetApp
Pancreatic, Brain Development Gene Found From Patient Exomes
In Brief This Week: Agendia, Genomics Medicine Ireland, Zymo Research, and More
Danaher Q1 Revenues Up 4 Percent

The Scan

Gene Therapy for SCID-X1

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

Same Scam, New Tech

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

To Guide the Genealogy Search

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

This Week in Nature

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.

Menu